Application Note

Transition To Closed Processing Systems For The Expansion Of Suspension Cells And Introduction Of Ballroom Format Cleanrooms For Cell Banking

GettyImages-1294339670-lab-cleanroom-PPE-computer-team

In response to the increasing biologics manufacturing industry shift into single-use, closed system processing technologies, as well as increasing regulatory requirements to de-risk processes1,2, our Rockville, Maryland, U.S. facility is moving routine expansion of suspension cells into a closed process format.

The closed system is designed to avoid exposure of the product or material to the room environment by connection of closed Erlenmeyer® flasks and culture components using sterile tubing and fusion systems, which will reduce contamination risk through reduction of operator intervention in the manufacturing process. Use of closed manufacturing systems allows expansion of production capacity by enabling multiple cultures to be present in the same processing area. By incorporating segregation techniques and developing cross contamination controls we are able to achieve a ‘ballroom’ format3 without additional changes to the key culture systems, in terms of main product contact material during incubation.

Learn about our transition to closed processes for expansion of suspension CHO and Sf9 cells and how the closed system compares to traditional processing.

VIEW THE APPLICATION NOTE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development